BioNTech Names Orphan Biovitrum's Guido Oelkers As New CEO, Replacing Ugur Sahin
BioNTech SE (NASDAQ:BNTX, "BioNTech" or "the Company"))) announced today that its Supervisory Board has appointed Guido Oelkers, Ph.D., to the Management Board as Chief Executive Officer ("CEO"),
BioNTech hired a new leader named Guido Oelkers to run the company instead of the old leader. When a company changes leaders, watch to see if the new person helps the company do better or if things stay the same.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.